Public Health

Cuba Issues Health Alert Over Suspected XFG Variant Spread
Clinical & Pharma Cuba Issues Health Alert Over Suspected XFG Variant Spread

Amid growing concerns over a potential new wave of respiratory illnesses, Cuban health authorities have issued a critical alert across multiple provinces due to the suspected presence of the XFG variant, a highly transmissible subvariant of the Omicron strain of the coronavirus. This development

Global Cancer Mortality Trends in Youth: Disparities Persist
Clinical & Pharma Global Cancer Mortality Trends in Youth: Disparities Persist

Cancer stands as a formidable challenge to the health of children, adolescents, and young adults across the globe, claiming countless lives each year with a burden that varies dramatically by region and circumstance. A comprehensive study analyzing data from 77 countries over a span of three

How Does Flooding Threaten Maternal Mental Health in Bangladesh?
Clinical & Pharma How Does Flooding Threaten Maternal Mental Health in Bangladesh?

In the low-lying deltas of rural Bangladesh, where climate change fuels relentless flooding, a silent crisis unfolds among pregnant women who face not only physical displacement but also profound psychological strain. This environmental challenge, intensified by rising sea levels and extreme

Can Trump Force Big Pharma to Slash US Drug Prices?
Clinical & Pharma Can Trump Force Big Pharma to Slash US Drug Prices?

Imagine a scenario where the cost of life-saving medications in the United States drops dramatically overnight, easing the financial burden on millions of families who struggle to afford essential drugs. This vision is at the heart of a recent bold move by President Donald Trump, who has directly

How Do Budgets Reshape American Medical Research?
Clinical & Pharma How Do Budgets Reshape American Medical Research?

The landscape of American medical research has seen a dramatic shift over recent decades, driven by the intricate dance between fiscal constraints and bureaucratic oversight at the National Institutes of Health (NIH), the nation’s premier health research agency. Once renowned for pioneering

Why Is Teva Pharma Stock Rising After Q2 2025 Results?
Clinical & Pharma Why Is Teva Pharma Stock Rising After Q2 2025 Results?

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has captured the attention of investors with a notable uptick in its stock price following the release of its second-quarter financial results, which showed a mix of challenges and successes. On Wednesday, the stock surged by 2.36% to $16.94, a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later